A Phase I/II Study of Carboplatin, Pemetrexed, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer

Phase 1

• Conditions: local advanced Non-small cell Lung Cancer(non-squamous)

• Registration Number: JPRN-UMIN000008426
• Lead Sponsor: Central Japan Lung Study Group(CJLSG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-07-13
• Study Completion: 2017-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1) Superior vena cava syndrome. 2) Lymph node metastases of opposite side hilum, malignant pleuritis, malignant pericarditis, lymphangitis. 3) Active infection or other serious disease condition (poorly controlled diabetes mellitus, unstable angina, cardiac infarction, psychological illness, etc.). 4) Pulmonary disorder (idiopathic pulmonary fibrosis, interstitial lung disease, pneumoconiosis, active radiation pneumonia, etc.). 5) With active double cancer. 6) Patient who joins other trial. 7) HBs antigen positive. 8) Severe drug allergy. 9) Pregnancy or lactation. 10) Patient whose participation in the trial is judged to be inappropriate by the attending doctor.

Study & Design

• Study Type: Interventional
• Study Design: Not specified